In line with human evidence, the accumulation of immunosuppressive and tumor-promoting TAMs was also confirmed in different pre-clinical models of MPM [77,78], where their depletion and/or M1-reprograming rescued anti-tumor immunity [78], in particular in combination with anti-PD1/PD-L1 blockades [79]. This evidence concerns the gene CD274 and neoplasm.